Trial · NCT00854724

Puerarin Effects on Alcohol Drinking

NCT00854724, Phase 2, Completed, Mclean Hospital; results first posted 2011-08-12

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Puerarin Effects on Alcohol Drinking. Trials, record NCT00854724. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00854724

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Puerarin Effects on Alcohol Drinking
NCT number: NCT00854724
Status: Completed
Phases: Phase 2
Enrollment: 16 participants, actual
Lead sponsor: Mclean Hospital
Conditions: Alcohol Abuse
Interventions: Puerarin, Placebo
First posted: 2009-03-03
Last updated: 2011-09-09
Results first posted: 2011-08-12

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Amount of Alcohol Consumed	During a 90 minute drinking session

Source ClinicalTrials.gov

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Amount of Alcohol Consumed	During a 90 minute drinking session		Number of drinks consumed	MEAN

Source ClinicalTrials.gov

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Category	Value	Spread	Units
Amount of Alcohol Consumed	Placebo, Then Puerarin		3.46	Standard Error 0.55	Number of drinks consumed
Amount of Alcohol Consumed	Puerarin, Then Placebo		2.36	Standard Error 0.41	Number of drinks consumed

Source ClinicalTrials.gov

Participant flow18

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
First Intervention	STARTED	Placebo, Then Puerarin	8
First Intervention	STARTED	Puerarin, Then Placebo	8
First Intervention	COMPLETED	Placebo, Then Puerarin	7
First Intervention	COMPLETED	Puerarin, Then Placebo	7
First Intervention	NOT COMPLETED	Placebo, Then Puerarin	1
First Intervention	NOT COMPLETED	Puerarin, Then Placebo	1
Washout	STARTED	Placebo, Then Puerarin	7
Washout	STARTED	Puerarin, Then Placebo	7
Washout	COMPLETED	Placebo, Then Puerarin	6
Washout	COMPLETED	Puerarin, Then Placebo	6

1 to 10 of 18Source ClinicalTrials.gov

See all 18 participant flow

Adverse events10

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events
other	headache	General disorders	Placebo, Then Puerarin	1	8	1
other	headache	General disorders	Puerarin, Then Placebo	0	8	0
other	Nausea	Gastrointestinal disorders	Placebo, Then Puerarin	2	8	2
other	Nausea	Gastrointestinal disorders	Puerarin, Then Placebo	1	8	1
other	Urinary Tract infection	Renal and urinary disorders	Placebo, Then Puerarin	1	8	1
other	Urinary Tract infection	Renal and urinary disorders	Puerarin, Then Placebo	0	8	0
other	Cheek Pain	Musculoskeletal and connective tissue disorders	Placebo, Then Puerarin	0	8	0
other	Cheek Pain	Musculoskeletal and connective tissue disorders	Puerarin, Then Placebo	1	8	1
other	Elevated Liver Enzymes	Hepatobiliary disorders	Placebo, Then Puerarin	0	8	0
other	Elevated Liver Enzymes	Hepatobiliary disorders	Puerarin, Then Placebo	1	8	1

Source ClinicalTrials.gov

Adverse event totals6

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo, Then Puerarin
Total, all-cause mortality	Puerarin, Then Placebo
Total, other adverse events	Placebo, Then Puerarin	4	8
Total, other adverse events	Puerarin, Then Placebo	3	8
Total, serious adverse events	Placebo, Then Puerarin	0	8
Total, serious adverse events	Puerarin, Then Placebo	0	8

Source ClinicalTrials.gov

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as
15897719	BACKGROUND

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Placebo, Then Puerarin vs Puerarin, Then Placebo: serious adverse events

Source Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00854724

GET https://conductscience.org/api/trials/v1/NCT00854724/registered

API reference For AI assistants